Niegisch G - Search Results

1

Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors.

Hoffmann MJ, Dehn J, Droop J, Niegisch G, Niedworok C, Szarvas T, Schulz WA. Hoffmann MJ, et al. Among authors: niegisch g. Noncoding RNA. 2015 Dec 17;1(3):266-284. doi: 10.3390/ncrna1030266. Noncoding RNA. 2015. PMID: 29861427 Free PMC article.

2

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.

Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA. Niegisch G, et al. Urol Oncol. 2013 Nov;31(8):1770-9. doi: 10.1016/j.urolonc.2012.06.015. Epub 2012 Sep 1. Urol Oncol. 2013. PMID: 22944197

3

HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma.

Kreimer U, Schulz WA, Koch A, Niegisch G, Goering W. Kreimer U, et al. Among authors: niegisch g. Front Oncol. 2013 Sep 26;3:255. doi: 10.3389/fonc.2013.00255. eCollection 2013. Front Oncol. 2013. PMID: 24133654 Free PMC article.

4

MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer.

Nikpour M, Emadi-Baygi M, Fischer U, Niegisch G, Schulz WA, Nikpour P. Nikpour M, et al. Among authors: niegisch g. Urol Oncol. 2014 Jul;32(5):670-7. doi: 10.1016/j.urolonc.2013.11.005. Epub 2014 Feb 2. Urol Oncol. 2014. PMID: 24495449

5

Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells.

Rosik L, Niegisch G, Fischer U, Jung M, Schulz WA, Hoffmann MJ. Rosik L, et al. Among authors: niegisch g. Cancer Biol Ther. 2014 Jun 1;15(6):742-57. doi: 10.4161/cbt.28469. Epub 2014 Mar 11. Cancer Biol Ther. 2014. PMID: 24618845 Free PMC article.

6

Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.

Weilandt M, Koch A, Rieder H, Deenen R, Schwender H, Niegisch G, Schulz WA. Weilandt M, et al. Among authors: niegisch g. Cancer Genomics Proteomics. 2014 May-Jun;11(3):141-53. Cancer Genomics Proteomics. 2014. PMID: 24969694

7

Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.

Lehmann M, Hoffmann MJ, Koch A, Ulrich SM, Schulz WA, Niegisch G. Lehmann M, et al. Among authors: niegisch g. J Exp Clin Cancer Res. 2014 Jul 10;33(1):59. doi: 10.1186/s13046-014-0059-8. J Exp Clin Cancer Res. 2014. PMID: 25011684 Free PMC article.

8

Canonical Notch signalling is inactive in urothelial carcinoma.

Greife A, Jankowiak S, Steinbring J, Nikpour P, Niegisch G, Hoffmann MJ, Schulz WA. Greife A, et al. Among authors: niegisch g. BMC Cancer. 2014 Aug 29;14:628. doi: 10.1186/1471-2407-14-628. BMC Cancer. 2014. PMID: 25167871 Free PMC article.

9

Multiple mechanisms mediate resistance to sorafenib in urothelial cancer.

Knievel J, Schulz WA, Greife A, Hader C, Lübke T, Schmitz I, Albers P, Niegisch G. Knievel J, et al. Among authors: niegisch g. Int J Mol Sci. 2014 Nov 7;15(11):20500-17. doi: 10.3390/ijms151120500. Int J Mol Sci. 2014. PMID: 25387078 Free PMC article.

10

Epigenetics of urothelial carcinoma.

Schulz WA, Koutsogiannouli EA, Niegisch G, Hoffmann MJ. Schulz WA, et al. Among authors: niegisch g. Methods Mol Biol. 2015;1238:183-215. doi: 10.1007/978-1-4939-1804-1_10. Methods Mol Biol. 2015. PMID: 25421661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page